Worldwide Wearable Medical Devices Industry Report to 2031 – Players Include Xiaomi Technology, BioTelemetry, Fitbit, Garmin and Apple – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Wearable Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031” report has been added to ResearchAndMarkets.com’s offering. This report on the global wearable medical devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market … [Read more…]

Tsing Hua University Hospital Preparatory Office Officially Opens in Taoyuan

HSINCHU, Taiwan–(BUSINESS WIRE)–#NTHU–On August 20, the Tsing Hua University Hospital Preparatory Office was officially opened in the Xinkong Building at the Taoyuan Metro Corporation’s Qingpu Depot, which is only one MRT station away from the site where the Hospital will be built. NTHU and the Taoyuan City Government have already signed a letter of intent … [Read more…]

Sensorion Reports 2022 First Half Results

Continued progress toward planned development for SENS-401 and gene therapy programs Positive progress for two clinical trials for SENS-401: in Cisplatin-Induced Ototoxicity (CIO) and to prevent residual hearing loss following cochlear implantation Development milestone achieved for the OTOF-GT program with delivery of batches for the toxicology study; plan to file Clinical Trial Application in 1H … [Read more…]

P3 Health Partners CEO Dr. Sherif Abdou to Speak at Nephron 2nd Annual Physician Enablement Symposium

HENDERSON, Nev.–(BUSINESS WIRE)–P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its Chief Executive Officer, Dr. Sherif Abdou, will participate on the “Next Frontier – Value Based Care for Sub-Capitation/Specialties” virtual panel at the Nephron 2nd Annual Physician Enablement Symposium on Thursday, September 22nd at 9:00 am … [Read more…]

ADC Therapeutics Announces Abstracts to be Presented at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022)

Initial safety run‐in results from LOTIS-5 Phase 3 trial demonstrate ORR of 75% and 40% CR rate with no new safety signals Cami pivotal Phase 2 data to be highlighted in encore oral and poster presentations LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE: ADCT) today announced that ZYNLONTA® (loncastuximab tesirine-lpyl) and camidanlumab tesirine (Cami) abstracts have … [Read more…]

Alnylam Announces New Management Appointments

– Piyush Sharma to Serve as Chief Ethics and Compliance Officer and Evan Lippman as Chief Corporate Development and Strategy Officer – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the appointment of two new members to the management team – Piyush Sharma as Chief Ethics & Compliance Officer … [Read more…]

UHSM Celebrates World Gratitude Day

Healthsharing ministry shares helpful practices for developing gratitude to overcome the negative effects of the pandemic on mental health NORFOLK, Va.–(BUSINESS WIRE)–Unite Health Share Ministries™ (UHSM), a nonprofit, faith-based healthcare sharing ministry supporting Christian believers through member-to-member healthcare sharing memberships, celebrates World Gratitude Day Wednesday, September 21st, by sharing the benefits of practicing gratitude and … [Read more…]

 Enlace Health Continues the Evolution to Sustainable Healthcare at Healthcare Evolution Connect

NASHVILLE, Tenn.–(BUSINESS WIRE)–#SustainableHealthcare—On September 14, 2022, Health Evolution Connect, an invitation-only event, kicked off with a networking event hosted by Enlace Health, a healthcare transformation company that powers the systematic changes needed for sustainable healthcare. Participants included CEO and C-Suite executives from providers, payers, and life science organizations, along with technology leaders, investors, innovators, and … [Read more…]

Global Coalition for Adaptive Research Announces That Regorafenib Has Completed Follow-up in the GBM AGILE Trial for Patients With Glioblastoma

LARKSPUR, Calif.–(BUSINESS WIRE)–#GBMAGILE–Global Coalition for Adaptive Research (GCAR), Sponsor of GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) master protocol, announced that regorafenib has completed enrollment and follow-up in GBM AGILE. Enrollment for the arm was stopped after an interim analysis showed a low probability of sufficient improvement in overall survival as compared with randomized … [Read more…]

Quality and GMP Compliance for Virtual Companies Seminar: Pharmaceutical and Biologics Industries – September 28-29, 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Quality and GMP Compliance for Virtual Companies (Pharmaceutical and Biologics Industries)” training has been added to ResearchAndMarkets.com’s offering. In this two-day workshop conference, you will learn the requirements and expectations of major healthcare regulators that are applicable to “virtual” companies. Today, many companies operate on an outsourcing model. This is very common for … [Read more…]